Anti-SSB/La
Also known as: La Antibodies, SSB Antibodies
What Does Anti-SSB/La Measure?
Anti-SSB/La is a blood test that detects autoantibodies directed against the La (SSB) protein, a ribonucleoprotein involved in RNA processing and transcription within the cell nucleus. The La protein plays an essential role in stabilizing and processing small RNA molecules, particularly those made by RNA polymerase III. When the immune system mistakenly identifies this protein as foreign, it produces antibodies against it, which can be detected in the bloodstream through specialized laboratory tests such as ELISA, immunofluorescence, or immunodiffusion.
Why Does Anti-SSB/La Matter?
Anti-SSB/La antibodies are clinically significant because they are strongly associated with autoimmune conditions, most notably primary Sjögren's syndrome and systemic lupus erythematosus (SLE). They are typically found alongside Anti-SSA/Ro antibodies and their combined presence helps confirm a diagnosis of Sjögren's syndrome with high specificity. Beyond diagnosis, these antibodies carry important prognostic value — their presence in pregnant women with autoimmune disease is associated with a risk of neonatal lupus and congenital heart block in the newborn, making early detection essential for maternal-fetal monitoring and management.
Normal Ranges
Males
Negative (< 1.0 U/mL or below laboratory-specific cutoff)
Females
Negative (< 1.0 U/mL or below laboratory-specific cutoff)
Children
Negative (< 1.0 U/mL or below laboratory-specific cutoff)
Causes of High Levels
- Primary Sjögren's syndrome — the most common cause, present in approximately 40–60% of patients
- Systemic lupus erythematosus (SLE) — found in 10–15% of SLE patients, often alongside Anti-SSA/Ro
- Secondary Sjögren's syndrome associated with other autoimmune diseases such as rheumatoid arthritis or scleroderma
- Neonatal lupus — maternal Anti-SSB/La antibodies can cross the placenta, causing transient autoimmunity in newborns
- Mixed connective tissue disease (MCTD) — occasionally positive in overlap syndromes
- Subacute cutaneous lupus erythematosus (SCLE) — may be detected in a subset of patients
Causes of Low Levels
- No true pathological causes of low Anti-SSB/La exist, as a negative result is the normal and expected finding
- Successful immunosuppressive therapy may reduce previously elevated antibody titers in some patients
How to Improve Your Anti-SSB/La
Diet
- Follow an anti-inflammatory diet rich in omega-3 fatty acids from fatty fish (salmon, sardines, mackerel) to help modulate immune activity
- Increase intake of antioxidant-rich fruits and vegetables such as blueberries, spinach, and broccoli to reduce oxidative stress
- Minimize processed foods, refined sugars, and trans fats, which can promote systemic inflammation and immune dysregulation
- Stay well hydrated with water and herbal teas, especially important in Sjögren's syndrome where dryness symptoms are prevalent
- Consider a Mediterranean-style diet, which has demonstrated benefits in reducing autoimmune flare frequency and inflammatory markers
Supplements
- Vitamin D3 (1,000–4,000 IU/day) — low vitamin D is associated with increased autoimmune activity; supplementation under medical guidance may help modulate immune responses
- Omega-3 fish oil (2–3 g/day of combined EPA and DHA) — has anti-inflammatory properties that may benefit autoimmune conditions
- N-Acetylcysteine (NAC, 600 mg twice daily) — an antioxidant that may support immune regulation and reduce oxidative damage in autoimmune conditions
- Probiotics (multi-strain, 10–50 billion CFU/day) — emerging evidence suggests gut microbiome balance plays a role in autoimmune modulation
Related Biomarkers
Frequently Asked Questions
What does a positive Anti-SSB/La test result mean?
A positive Anti-SSB/La result means your immune system is producing antibodies against the La (SSB) protein found in cell nuclei. This is not a normal finding and is most commonly associated with autoimmune conditions, particularly Sjögren's syndrome and lupus (SLE). However, a positive result alone does not confirm a diagnosis — your doctor will interpret it alongside your symptoms, physical examination, and other laboratory tests before reaching a conclusion.
What is the difference between Anti-SSA/Ro and Anti-SSB/La?
Anti-SSA/Ro and Anti-SSB/La are both autoantibodies commonly found together in Sjögren's syndrome and lupus. Anti-SSA/Ro targets the Ro protein and is more common and sensitive for these conditions, while Anti-SSB/La targets the La protein and tends to be more specific for primary Sjögren's syndrome. Having both antibodies together — especially in a woman of childbearing age — is particularly important because both can cross the placenta and increase the risk of neonatal lupus and congenital heart block in the baby.
Can Anti-SSB/La antibodies affect pregnancy?
Yes, this is an important consideration. Anti-SSB/La antibodies (along with Anti-SSA/Ro antibodies) can cross the placenta from mother to baby during pregnancy. In the baby, these maternal antibodies can cause a temporary condition called neonatal lupus, which may include a skin rash, liver abnormalities, and low blood counts that usually resolve within 6 months. More seriously, they can cause congenital heart block, a potentially life-threatening condition where the baby's heart rate becomes abnormally slow. Pregnant women who test positive are typically monitored with fetal echocardiograms during the second trimester.